Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
50%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph not_applicable
2
33%
Ph phase_4
1
17%
Ph phase_1
2
33%

Phase Distribution

2

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Not yet recruiting2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

terminated117%
completed233%
active_not_recruiting117%
not_yet_recruiting233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
OTHER
Total Trials
6